| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.9 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | 0.0053 | 0.9 |
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | -0.0065 | 0.9 |
| mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | 0.0046 | 0.9 |
| mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | 0.0061 | 0.9 |
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | -0.0061 | 0.9 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | 0.005 | 0.9 |
| mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.9 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | -0.007 | 0.9 |
| mRNA | JNJ-26854165 | GDSC1000 | pan-cancer | AAC | -0.0051 | 0.9 |